Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Foster MART vs Foster + Salbutamol in Asthmatics
NCT00861926Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Mar 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 14
01
Overview
Phase 3, randomised, double-blind trial of beclomethasone dipropionate and formoterol in asthma (2 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoints: Time to First Severe Asthma Exacerbation at 48 weeks and Cumulative Number of Patients With Severe Asthma Exacerbation by Inter-visit at 48 weeks. Started Mar 2009; status: completed.
02
Drugs
beclomethasone dipropionateformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00861926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00861926.